Clinical Trial Update: Toripalimab Plus Sorafenib in Patients With Advanced-Stage Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating toripalimab in combination with sorafenib for advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN